GlySure’s Technology May Break Barrier For Tight Control And Automated Glucose Monitoring
GlySure’s technology enables a healthcare facility to implement tight glycemic control and intensive insulin therapy.
GlySure’s technology enables a healthcare facility to implement tight glycemic control and intensive insulin therapy.
Cervilenz has developed an innovative low cost, single use medical device that accurately measures a pregnant woman’s cervical length, which is the best indicator of preterm birth risk.
Bio-Path Holdings has developed a powerful drug delivery technology that utilizes cell-like drug carriers, termed liposomes, which avoid drug breakdown.
ADS Biotechnology has developed a breakthroughtechnology that upon administration immediately prevents any further blood vessel leakage, thereby effectively treating and reversing CLS.
ADVENTRX and SynthRx, a private biotechnology company, completed a definitive merger on April 8, 2011.
Ikonisys is a medical devices company that has developed a combinatorial technological platform using molecular biology and imaging methodology for the detection of rare cells, […]
Technology that enables the fast and sensitive detection of biological and disease specific markers in live tissue is a major need in the diagnostic field. […]
Applied NeuroSolutions is a specialty biopharmaceutical company that is developing unprecedented early diagnostic tests and therapeutics for Alzheimer’s disease. The company’s technological platform is based […]
Optomed is a medical devices company that has developed state of the art digital imaging systems for ophthalmologic (eye) analysis. The company’s latest development is […]
Antibody based diagnostics and therapeutics represent a major medical advance as they respectively identify diseases with high specificity and preclude systemic side effects by recognizing […]
Copyright © 2024 | WordPress Theme by MH Themes